Trafalgar International (GCAN) Acquisitions (2020)
Greater Cannabis Company (GCAN) posted quarterly Acquisitions of $25000.0 for Q1 2020.
Trafalgar International (GCAN) Acquisitions (2020) Analysis & Trends
Greater Cannabis Company's Acquisitions history runs 1 years deep, the most recent figure standing at $25000.0 for Q1 2020.
- In Q1 2020, Acquisitions changed N/A year-over-year to $25000.0; the TTM figure through Dec 2020 stood at $25000.0 (changed N/A YoY), while the FY2020 annual figure was $25000.0, changed N/A from the prior year.
- Acquisitions for Q1 2020 stood at $25000.0.
- The five-year high for Acquisitions was $25000.0 in Q1 2020, with the low at $25000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 25,000.00 |